
|Articles|March 1, 2003
Azelaic Hailed
Birmingham, Ala. - Topical azelaic acid 15 percent gel (Finacea) is more effective than metronidazole gel 0.75 percent for improving erythema and reducing inflammatory lesion counts in patients with mild to moderate papulopustular facial rosacea, according to the results of a multicenter, double-blind, randomized, parallel comparative trial.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
2
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
5











